Strategic Partners A/S OZYMF Stock
Strategic Partners A/S Price Chart
Strategic Partners A/S OZYMF Financial and Trading Overview
Strategic Partners A/S stock price | 90 USD |
Previous Close | 0.12 USD |
Open | 0.12 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.12 - 0.12 USD |
52 Week Range | 0.01 - 0.39 USD |
Volume | 100 USD |
Avg. Volume | 1 USD |
Market Cap | 9.1M USD |
Beta (5Y Monthly) | 0.342145 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2471.19 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
OZYMF Valuation Measures
Enterprise Value | -38155908 USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.10338984 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | 1.361 |
Trading Information
Strategic Partners A/S Stock Price History
Beta (5Y Monthly) | 0.342145 |
52-Week Change | -68.76% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.39 USD |
52 Week Low | 0.01 USD |
50-Day Moving Average | 0.12 USD |
200-Day Moving Average | 0.16 USD |
OZYMF Share Statistics
Avg. Volume (3 month) | 1 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 35.31M |
Float | 25.8M |
Short Ratio | N/A |
% Held by Insiders | 1.35% |
% Held by Institutions | 7.14% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -22.28% |
Return on Equity (ttm) | -150.22% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -28028000 USD |
Net Income Avi to Common (ttm) | -38312000 USD |
Diluted EPS (ttm) | -2.46 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 42.46M USD |
Total Cash Per Share (mrq) | 1.2 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 3.553 |
Book Value Per Share (mrq) | 1.18 |
Cash Flow Statement
Operating Cash Flow (ttm) | -117945000 USD |
Levered Free Cash Flow (ttm) | -64086624 USD |
Profile of Strategic Partners A/S
Country | United States |
State | N/A |
City | Copenhagen |
Address | Ole Maaløes Vej 3 |
ZIP | 2200 |
Phone | 45 70 70 29 80 |
Website | https://www.orphazyme.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1 |
Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Q&A For Strategic Partners A/S Stock
What is a current OZYMF stock price?
Strategic Partners A/S OZYMF stock price today per share is 90 USD.
How to purchase Strategic Partners A/S stock?
You can buy OZYMF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Strategic Partners A/S?
The stock symbol or ticker of Strategic Partners A/S is OZYMF.
Which industry does the Strategic Partners A/S company belong to?
The Strategic Partners A/S industry is Biotechnology.
How many shares does Strategic Partners A/S have in circulation?
The max supply of Strategic Partners A/S shares is 71.07K.
What is Strategic Partners A/S Price to Earnings Ratio (PE Ratio)?
Strategic Partners A/S PE Ratio is now.
What was Strategic Partners A/S earnings per share over the trailing 12 months (TTM)?
Strategic Partners A/S EPS is -2471.19 USD over the trailing 12 months.
Which sector does the Strategic Partners A/S company belong to?
The Strategic Partners A/S sector is Healthcare.